Natural history of incidentally discovered, asymptomatic idiopathic dilated cardiomyopathy.

Keywords

Asymptomatic, Natural history, Medicine, Disease, Cardiomyopathy

References

• A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.Jay N. Cohn, Gary R. Johnson, Susan Ziesche — 1991
• The Clinical Course of Idiopathic Dilated CardiomyopathyD. Sugrue, Richard J. Rodeheffer, Mary Codd — 1992
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative StudyJay N. Cohn, Debbie Archibald, Susan Ziesche — 1987
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureJay N. Cohn, Donald Archibald, Susan Ziesche — 1986
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.Marc A. Pfeffer, Eugene Braunwald, Lemuel A. Moyé — 1992
• Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.The SOLVD Investigators* — 1992
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.The SOLVD Investigators* — 1991

Cited by

• Positron emission tomography: An additional prognostic tool in dilated cardiomyopathy?Danilo Neglia — 2016
• The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for ScreeningThomas J. Wang, Daniel Levy, Emelia J. Benjamin — 2003
• Prognosis and prognostic factors in patients with idiopathic dilated cardiomyopathy in Japan.Katsuyuki Miura, Akira Matsumori, Ali Nasermoaddeli — 2008
• Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategiesKarlijn A. Wouters, Leontien C.M. Kremer, Tracie L. Miller — 2005
• Heart transplant for pediatric cardiomyopathyCharles E. Canter, Paul F. Kantor — 2007
• Outer limits of the athlete's heart, the effect of gender, and relevance to the differential diagnosis with primary cardiac diseases.Antonio Pelliccia, Barry J. Maron — 1997
• Radiographic measurements of cardiac size as predictors of outcome in patients with dilated cardiomyopathy.Eric R. Ernst, Clarence Shub, Kent R. Bailey — 2001
• ANTHRACYCLINE CARDIOTOXICITY IN CHILDHOODAntonio Ruggiero, Vita Ridola, Nadia Puma — 2008
• Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure – a subgroup analysis from the Trieste Cardiomyopathy RegistryAneta Aleksova, Gastone Sabbadini, Marco Merlo — 2009
• Physiologic Left Ventricular Cavity Dilatation in Elite AthletesAntonio Pelliccia, Franco Culasso, Fernando M. Di Paolo — 1999
• Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes.Andrea Pelliccia — 1996
• Myocardial metabolic and receptor imaging in idiopathic dilated cardiomyopathyDanilo Neglia, Gianmario Sambuceti, Patricia Iozzo — 2002
• Usefulness of meta-[123I]iodobenzylguanidine myocardial scintigraphy for predicting cardiac events in patients with dilated cardiomyopathy who receive long-term beta blocker treatmentShinichiro Fujimoto, Aritomo Inoue, Shinji Hisatake — 2005
• La inmunoadsorción: ¿alternativa o adyuvante del tratamiento quirúrgico?José Luís Ayuso‐Mateos, J.A. Fernández-Divar, Jesús Herreros — 2011
• Comparative sensitivities between different plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure.W.H. Wilson Tang, Kiran Philip, Stanley L. Hazen — 2005
• An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapiesPatricia E. Zerra, Thomas R. Cochran, Vivian I. Franco — 2013
• Incremental Prognostic Value of Myocardial Fibrosis in Patients With Non–Ischemic Cardiomyopathy Without Congestive Heart FailurePier Giorgio Masci, Constantinos Doulaptsis, Erika Bertella — 2014
• Usefulness of123I-metaiodobenzylguanidine myocardial scintigraphy in the prediction of cardiac events in patients with cardiomyopathy showing stabilization of symptoms or preserved cardiac functionShinichiro Fujimoto, Hideo Amano, Aritomo Inoue — 2004
• Palpitations in idiopathic dilated cardiomyopathy.Simon W Dubrey, Rodney H. Falk — 1995
• Discrimination between physiologic and pathologic left ventricular dilatation.Hülya Kaşıkçıoğlu, Erdem Kaşıkçıoğlu, Hüseyin Oflaz — 2006

Related papers

• Natural History and Conservative Treatment Options in Chiari Malformation Type I in Adults: A Literature UpdateFernando Luíz Rolemberg Dantas, François Dantas, Antônio Carlos Vieira Caires — 2020
• The natural history of incidental retroperitoneal schwannomasAkira Ogose, Hiroyuki Kawashima, Koji Hatano — 2019
• P.014 The natural history of third ventricle colloid cysts includes asymptomatic regression: a report of two cases and review of the literatureRakan Bokhari, Jeffrey Chankowsky, J Marcoux — 2017
• Ultrasonographic screening for evaluation and follow-up of carotid artery ulceration. A new basis for assessing risk.John M. Johnson, A.Lee Ansel, Sandra P. Morgan — 1982
• The natural history of abdominal aortic aneurysm.Bent Skov Jensen, T. Vestersgaard-Andersen — 1989
• The natural history of asymptomatic complete heart block. A case series from the Manitoba Follow-up Study.A D Krahn, F al Mathewson, T. Edward Cuddy — 1992
• What is the Natural History of an Asymptomatic Renal Artery Stenosis: Is Treatment of Asymptomatic Lesions Justified?Thomas A. Sos, David Trost — 2005
• Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis.Philippe Généreux, Gregg W. Stone, Patrick T. O’Gara — 2016